SBC Medical Group Holdings Incorporated (SBC) - Net Assets
Based on the latest financial reports, SBC Medical Group Holdings Incorporated (SBC) has net assets worth $279.92 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($406.66 Million) and total liabilities ($126.74 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See how leveraged is SBC Medical Group Holdings Incorporated's balance sheet to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $279.92 Million |
| % of Total Assets | 68.83% |
| Annual Growth Rate | 34.64% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 0.96 |
SBC Medical Group Holdings Incorporated - Net Assets Trend (2022–2025)
This chart illustrates how SBC Medical Group Holdings Incorporated's net assets have evolved over time, based on quarterly financial data. Also explore how fast is SBC Medical Group Holdings Incorporated growing its equity to track the company's year-over-year net asset growth rate.
Annual Net Assets for SBC Medical Group Holdings Incorporated (2022–2025)
The table below shows the annual net assets of SBC Medical Group Holdings Incorporated from 2022 to 2025. For live market cap and overall valuation, see SBC market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $263.30 Million | +35.01% |
| 2024-12-31 | $195.02 Million | +35.61% |
| 2023-12-31 | $143.81 Million | +33.34% |
| 2022-12-31 | $107.85 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to SBC Medical Group Holdings Incorporated's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 132.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $240.45 Million | 96.84% |
| Common Stock | $10.39K | 0.00% |
| Other Comprehensive Income | $-57.29 Million | -23.08% |
| Other Components | $65.12 Million | 26.23% |
| Total Equity | $248.28 Million | 100.00% |
SBC Medical Group Holdings Incorporated Competitors by Market Cap
The table below lists competitors of SBC Medical Group Holdings Incorporated ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shenzhen Huijie Group Co Ltd
SHE:002763
|
$455.88 Million |
|
Shanghai SK Petroleum & Chemical Equipment Corp Ltd
SHE:002278
|
$456.07 Million |
|
I-Mab
NASDAQ:IMAB
|
$456.45 Million |
|
Visco Vision Inc.
TW:6782
|
$456.51 Million |
|
Ibersol SGPS
LS:IBS
|
$455.49 Million |
|
San Miguel AG
BA:SAMI
|
$455.49 Million |
|
Deutsche Pfandbriefbank AG
XETRA:PBB
|
$455.30 Million |
|
Xinxiang Tuoxin Pharmaceutical Co.Ltd.
SHE:301089
|
$455.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SBC Medical Group Holdings Incorporated's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 195,109,156 to 248,282,196, a change of 53,173,040 (27.3%).
- Net income of 50,985,613 contributed positively to equity growth.
- Share repurchases of 4,999,997 reduced equity.
- Other comprehensive income decreased equity by 3,116,165.
- Other factors increased equity by 10,303,589.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $50.99 Million | +20.54% |
| Share Repurchases | $5.00 Million | -2.01% |
| Other Comprehensive Income | $-3.12 Million | -1.26% |
| Other Changes | $10.30 Million | +4.15% |
| Total Change | $- | 27.25% |
Book Value vs Market Value Analysis
This analysis compares SBC Medical Group Holdings Incorporated's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.25x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.78x to 2.25x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | $6.99 | $5.42 | x |
| 2023-12-31 | $1.51 | $5.42 | x |
| 2024-12-31 | $2.02 | $5.42 | x |
| 2025-12-31 | $2.41 | $5.42 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SBC Medical Group Holdings Incorporated utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 20.54%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 29.37%
- • Asset Turnover: 0.46x
- • Equity Multiplier: 1.53x
- Recent ROE (20.54%) is above the historical average (19.53%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 6.00% | 3.63% | 0.77x | 2.14x | $-4.21 Million |
| 2023 | 27.69% | 20.34% | 0.75x | 1.82x | $25.15 Million |
| 2024 | 23.89% | 22.69% | 0.77x | 1.36x | $27.10 Million |
| 2025 | 20.54% | 29.37% | 0.46x | 1.53x | $26.16 Million |
Industry Comparison
This section compares SBC Medical Group Holdings Incorporated's net assets metrics with peer companies in the Consulting Services industry.
Industry Context
- Industry: Consulting Services
- Average net assets among peers: $146,744,992
- Average return on equity (ROE) among peers: 33.96%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SBC Medical Group Holdings Incorporated (SBC) | $279.92 Million | 6.00% | 0.45x | $455.61 Million |
| Acco Group Holdings Limited Ordinary Shares (ACCL) | $2.19 Million | 46.72% | 0.79x | $37.25 Million |
| Aeries Technology Inc. (AERT) | $8.70 Million | 46.37% | 1.17x | $36.19 Million |
| Booz Allen Hamilton Holding (BAH) | $408.49 Million | 72.00% | 6.37x | $8.89 Billion |
| CRA International Inc (CRAI) | $80.05 Million | 10.54% | 0.36x | $1.11 Billion |
| Diginex Limited Ordinary Shares (DGNX) | $-19.48 Million | 0.00% | 0.00x | $37.00 Million |
| Etoiles Capital Group Co., Ltd. Class A Ordinary Shares (EFTY) | $31.64K | 103.33% | 1.23x | $226.95 Million |
| Equifax Inc (EFX) | $523.60 Million | 44.82% | 1.97x | $17.36 Billion |
| ENIGMATIG LIMITED (EGG) | $12.41 Million | 3.43% | 0.14x | $126.76 Million |
| FTI Consulting Inc (FCN) | $454.27 Million | 12.41% | 1.11x | $3.76 Billion |
| Hang Feng Technology Innovation Co., Ltd. (FOFO) | $-2.80 Million | 0.00% | 0.00x | $15.27 Million |
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with… Read more